BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.54B |
| 2 |
iShares Global 100 ETF
IOO
|
+$1.1B |
| 3 |
Williams Companies
WMB
|
+$979M |
| 4 |
iShares Europe ETF
IEV
|
+$555M |
| 5 |
Prologis
PLD
|
+$523M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.32B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
GGP
GGP Inc.
GGP
|
+$1.17B |
| 4 |
SPDR Gold Trust
GLD
|
+$1.07B |
| 5 |
XL
XL Group Ltd.
XL
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.84% |
| 2 | Financials | 14.45% |
| 3 | Healthcare | 14.06% |
| 4 | Consumer Discretionary | 10.08% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Ennis
EBF
$558M
| $38.2M | ﹤0.01% |
1,869,736
+16,958
| +0.9% | +$358K |
|
|
RUBY
2527
DELISTED
Rubius Therapeutics, Inc
RUBY
| $38.2M | ﹤0.01% |
+1,589,798
| New | +$36.3M |
|
|
ORC
2528
Orchid Island Capital
ORC
$1.3B
| $38M | ﹤0.01% |
1,047,507
+52,655
| +5% | +$2.06M |
|
2529
TFS Financial
TFSL
$4.83B
| $38M | ﹤0.01% |
2,528,624
-225,868
| -8% | -$3.53M |
|
2530
Mercantile Bank Corp
MBWM
$1.05B
| $37.9M | ﹤0.01% |
1,136,353
+56,701
| +5% | +$2.02M |
|
|
SGYP
2531
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $37.9M | ﹤0.01% |
22,300,724
+568,670
| +3% | +$1.02M |
|
|
ADMS
2532
DELISTED
Adamas Pharmaceuticals
ADMS
| $37.8M | ﹤0.01% |
1,889,914
+43,818
| +2% | +$1.03M |
|
|
AIZP
2533
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
| $37.8M | ﹤0.01% |
331,569
+26,222
| +9% | +$2.98M |
|
2534
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $37.7M | ﹤0.01% |
790,622
-18,493
| -2% | -$879K |
|
|
KDNY
2535
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $37.6M | ﹤0.01% |
1,024,249
+82,944
| +9% | +$2.66M |
|
2536
POSCO
PKX
$17.7B
| $37.6M | ﹤0.01% |
570,142
-314,590
| -36% | -$22M |
|
|
ZAGG
2537
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $37.6M | ﹤0.01% |
2,548,418
+263,141
| +12% | +$4.18M |
|
|
SIEN
2538
DELISTED
Sientra, Inc.
SIEN
| $37.6M | ﹤0.01% |
157,290
+8,231
| +6% | +$1.81M |
|
2539
QCR Holdings
QCRH
$1.7B
| $37.5M | ﹤0.01% |
917,087
-202,088
| -18% | -$9M |
|
|
ACRE
2540
Ares Commercial Real Estate
ACRE
$256M
| $37.4M | ﹤0.01% |
2,678,523
+120,580
| +5% | +$1.71M |
|
|
KREF
2541
KKR Real Estate Finance Trust
KREF
$492M
| $37.4M | ﹤0.01% |
1,852,794
+767,114
| +71% | +$15.8M |
|
|
DAY
2542
DELISTED
Dayforce
DAY
| $37.3M | ﹤0.01% |
887,948
+19,811
| +2% | +$725K |
|
2543
Seaboard Corp
SEB
$4.06B
| $37.3M | ﹤0.01% |
10,052
-77
| -0.8% | -$287K |
|
2544
NVE Corp
NVEC
$573M
| $37.1M | ﹤0.01% |
350,595
+4,261
| +1% | +$491K |
|
|
RARX
2545
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $37.1M | ﹤0.01% |
2,049,933
+512,602
| +33% | +$6.08M |
|
2546
iShares US Treasury Bond ETF
GOVT
$43.6B
| $37.1M | ﹤0.01% |
1,523,508
-299,573
| -16% | -$7.34M |
|
2547
Peapack-Gladstone Financial
PGC
$800M
| $37.1M | ﹤0.01% |
1,199,738
+19,669
| +2% | +$656K |
|
2548
Solid Biosciences
SLDB
$918M
| $36.7M | ﹤0.01% |
51,883
+12,154
| +31% | +$7.64M |
|
2549
Bristow Group
VTOL
$1.38B
| $36.7M | ﹤0.01% |
1,483,934
+98,213
| +7% | +$2.51M |
|
2550
Aclaris Therapeutics
ACRS
$867M
| $36.6M | ﹤0.01% |
2,517,412
+205,771
| +9% | +$3.53M |
|
Similar funds
BlackRock's Q3 2018 Portfolio in Review
As of Q3 2018, BlackRock held 5,206 positions worth $2.31T, up 6.5% from $2.17T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q3 2018 filing shows 149 new, 3,074 increased, 1,229 reduced and 164 closed positions. Its largest new stake was iShares Asia 50 ETF: 5,580,513 shares worth $349M. The largest sale was Apple, an estimated $3.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q3 2018 buy was iShares Asia 50 ETF: 5,580,513 shares worth $349M.
- BlackRock added most to iShares Core S&P 500 ETF in Q3 2018, an estimated $1.54B increase.
- BlackRock's biggest Q3 2018 reduction was Apple, cutting an estimated $3.32B.
- BlackRock fully exited GGP Inc. in Q3 2018, selling an estimated $1.17B.
- BlackRock's ten largest holdings make up 15% of its $2.31T portfolio in Q3 2018.
- BlackRock opened 149 new positions and closed 164 in Q3 2018.
- BlackRock's portfolio value rose 6.5% quarter-over-quarter to $2.31T.
Based on BlackRock's 13F filing for Q3 2018, filed 9 Nov 2018.